title: Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology.
abstract: Multiple sclerosis has become an ever-increasing challenge to neurologists. With the release of the latest medications on the market, Brazilian neurologists feel divided between following their patients' evolution in accordance with the strict rules established by the Brazilian Ministry of Health regarding drug distribution, or following disease progression and worsening in accordance with the evidence in the literature. Therefore, a systematic review of the main published treatment guidelines was conducted and an escalating therapy proposed for guiding multiple sclerosis patient treatment in Brazil.
authors.affiliation: Universidade José do Rosário Vellano, UNIFENAS, Belo Horizonte MG, Brasil.|Academia Brasileira de Neurologia, Departamento Científico de Neuroimunologia (DCNI), São Paulo SP, Brasil.
authors.forename: Elizabeth Regina
authors.initials: ER
authors.lastname: Comini-Frota
authors.affiliation: Universidade Federal do Estado do Rio de Janeiro, Departamento de Neurologia, Rio de Janeiro RJ, Brasil.|Academia Brasileira de Neurologia, Departamento Científico de Neuroimunologia (DCNI), São Paulo SP, Brasil.
authors.forename: Cláudia C F
authors.initials: CC
authors.lastname: Vasconcelos
authors.affiliation: Santa Casa de São Paulo, Departamento de Neurologia, São Paulo SP, Brasil.|Academia Brasileira de Neurologia, Departamento Científico de Neuroimunologia (DCNI), São Paulo SP, Brasil.
authors.forename: Maria Fernanda
authors.initials: MF
authors.lastname: Mendes
mesh_terms: D000047:Academies and Institutes; D032921:Consensus; D019317:Evidence-Based Medicine; D017408:Guidelines as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*